| Product Code: ETC7660550 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to import significant quantities of Ramipril, with top exporting countries being Switzerland, UK, Belgium, USA, and Germany. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low in 2024, indicating a diverse import market for Ramipril. The compound annual growth rate (CAGR) from 2020 to 2024 was -2.14%, showing a slight decline in demand over the period. Additionally, the growth rate in 2024 decreased by -0.41%, suggesting a further slowdown in the importation of Ramipril into Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Ramipril Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Ramipril Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Ramipril Market - Industry Life Cycle |
3.4 Israel Ramipril Market - Porter's Five Forces |
3.5 Israel Ramipril Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Ramipril Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Israel Ramipril Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.8 Israel Ramipril Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Ramipril Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hypertension and cardiovascular diseases in Israel |
4.2.2 Growing awareness about the benefits of using ramipril for managing hypertension |
4.2.3 Favorable government initiatives promoting healthcare access and affordability in Israel |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and market entry |
4.3.2 Competition from other ACE inhibitors and alternative treatment options in the market |
5 Israel Ramipril Market Trends |
6 Israel Ramipril Market, By Types |
6.1 Israel Ramipril Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Ramipril Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Ramipril Market Revenues & Volume, By Tablets, 2021- 2031F |
6.1.4 Israel Ramipril Market Revenues & Volume, By Capsules, 2021- 2031F |
6.1.5 Israel Ramipril Market Revenues & Volume, By Solutions, 2021- 2031F |
6.2 Israel Ramipril Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Israel Ramipril Market Revenues & Volume, By High Blood Pressure, 2021- 2031F |
6.2.3 Israel Ramipril Market Revenues & Volume, By Heart Failure, 2021- 2031F |
6.2.4 Israel Ramipril Market Revenues & Volume, By Diabetic Kidney Disease, 2021- 2031F |
6.3 Israel Ramipril Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Israel Ramipril Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Israel Ramipril Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Israel Ramipril Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4 Israel Ramipril Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Israel Ramipril Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Israel Ramipril Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.4.4 Israel Ramipril Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Israel Ramipril Market Import-Export Trade Statistics |
7.1 Israel Ramipril Market Export to Major Countries |
7.2 Israel Ramipril Market Imports from Major Countries |
8 Israel Ramipril Market Key Performance Indicators |
8.1 Number of prescriptions for ramipril by healthcare providers |
8.2 Patient adherence rate to ramipril treatment |
8.3 Number of clinical studies and research publications supporting the efficacy of ramipril in Israel |
9 Israel Ramipril Market - Opportunity Assessment |
9.1 Israel Ramipril Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Ramipril Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Israel Ramipril Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.4 Israel Ramipril Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Ramipril Market - Competitive Landscape |
10.1 Israel Ramipril Market Revenue Share, By Companies, 2024 |
10.2 Israel Ramipril Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here